ResMed (ResMed) Price-to-Operating-Cash-Flow

: 25.18 (As of Today)

View and export this data going back to 1995. Start your Free Trial

As of today (2024-04-24), ResMed's share price is $184.22. ResMed's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $7.32. Hence, ResMed's Price-to-Operating-Cash-Flow Ratio for today is 25.18.

The historical rank and industry rank for ResMed's Price-to-Operating-Cash-Flow or its related term are showing as below:

RMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 15.58 Med: 29.23 Max: 101.3
Current: 25.18

During the past 13 years, ResMed's highest Price-to-Operating-Cash-Flow Ratio was 101.30. The lowest was 15.58. And the median was 29.23.

RMD's Price-to-Operating-Cash-Flow is ranked worse than
60.5% of 438 companies
in the Medical Devices & Instruments industry
Industry Median: 20.61 vs RMD: 25.18

ResMed's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $1.85. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $7.32.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of ResMed was 190.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -5.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 1.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 4.50% per year.

During the past 13 years, ResMed's highest 3-Year average Operating Cash Flow per Share Growth Rate was 78.60% per year. The lowest was -9.10% per year. And the median was 21.70% per year.

ResMed Price-to-Operating-Cash-Flow Historical Data

The historical data trend for ResMed's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

38.41

34.86

49.01

87.78

46.47

ResMed Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															82.72	60.26	46.47	23.33	23.52

Competitive Comparison

For the Medical Instruments & Supplies subindustry, ResMed's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ResMed Price-to-Operating-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ResMed's Price-to-Operating-Cash-Flow falls into.

ResMed Price-to-Operating-Cash-Flow Calculation

ResMed's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	184.22	/	7.315
	=	25.18

ResMed's Share Price of today is $184.22.
ResMed's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.32.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

ResMed Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ResMed's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed (ResMed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (NYSE:RMD) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMEA:Germany RME:Germany RMEA:Germany RME:Germany R1MD34:Brazil RMD:Australia

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Executives

Brett Sandercock	officer: Chief Financial Officer	17 GUINEVIERE COURT, CASTLE HILL, NEW SOUTH WALES C3 2154
Michael J. Farrell	officer: Chief Executive Officer	C/O REMED INC, 9001 SPECTRUM CTR. BLVD., SAN DIEGO, CA 92123
Michael J Rider	officer: Global General Counsel	9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
Robert Andrew Douglas	officer: President and COO	21 ATTUNGA ROAD, NEWPORT, NEW SOUTH WALES C3 2106
Kaushik Ghoshal	officer: President, SaaS Business	9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
David Pendarvis	officer: Chief Administration Officer	REDMED INC, 14040 DANLELSON ST, POWAY CA 92064
Karen Drexler	director	C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Justin Leong	officer: President, Asia and LATAM	C/O RESMED INC, 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
Desney Tan	director	9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
John Hernandez	director	9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123
Lucile Blaise	officer: President, Sleep & RC Business	RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123
Peter C Farrell	director	RESMED INC, 14040 DANIELSON STREET, POWAY CA 92064-6857
James Hollingshead	officer: President, Sleep Business	C/O RESMED INC., 9001 SPECTRUM CENTER BOULEVARD, SAN DIEGO CA 92123
Carol Burt	director	C/O WELLCARE HEALTH PLANS, INC., 8725 HENDERSON ROAD, TAMPA FL 33634
Resmed Inc	director	9001 SPECTRUM CENTER BLVD., SAN DIEGO CA 92123